Gut microbiota profiling reflects the renal dysfunction and psychological distress in patients with diabetic kidney disease

被引:2
作者
Li, Qi [1 ,2 ]
Xie, Suyi [3 ]
Liu, Yali [4 ]
Yue, Wei [4 ]
Wang, Limin [5 ]
Liang, Yi [4 ]
Chen, Yan [4 ]
Yuan, Huijuan [5 ]
Yu, Jiawei [4 ]
机构
[1] Zhengzhou Univ, Heart Ctr Henan Prov Peoples Hosp, Henan Key Lab Coronary Heart Dis Prevent & Control, Dept Cardiol ,Cent China Fuwai Hosp, Zhengzhou, Peoples R China
[2] Karolinska Inst, Dept Med Huddinge, Huddinge, Sweden
[3] Chinese Univ Hong Kong, Fac Med, Dept Psychiat, Li Chiu Kong Family Sleep Assessment Unit, Hong Kong, Peoples R China
[4] Peoples Liberat Army, Hosp 988, Joint Logist Support Forces, Dept Nephrol, Zhengzhou, Henan, Peoples R China
[5] Zhengzhou Univ, Henan Univ, Peoples Hosp, Henan Prov Peoples Hosp,Dept Endocrinol,Henan Prov, Zhengzhou, Peoples R China
来源
FRONTIERS IN ENDOCRINOLOGY | 2024年 / 15卷
关键词
gut microbiota; diabetic kidney disease; end-stage renal disease; renal dysfunction; psychological distress; ANXIETY; DEPRESSION; MELLITUS; SCALE;
D O I
10.3389/fendo.2024.1410295
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The gut microbiota plays a pivotal role in the development of diabetes and kidney disease. However, it is not clear how the intestinal microecological imbalance is involved in the context of diabetic kidney disease (DKD), the leading cause of renal failure.Objectives To elucidate the gut microbial signatures associated with DKD progression towards end-stage renal disease (ESRD) and explore whether they could reflect renal dysfunction and psychological distress.Methods A cross-sectional study was conducted to explore the gut microbial signatures of 29 DKD non-ESRD patients and 19 DKD ESRD patients compared to 20 healthy controls. Differential analysis was performed to detect distinct gut microbial alterations in diversities and taxon abundance of DKD with and without ESRD. Renal dysfunction was estimated by urea, creatinine, and estimated glomerular filtration rate. Psychological distress was assessed using the Self-Rating Anxiety Scale, Self-Rating Depression Scale, Hamilton Anxiety Rating Scale, and Hamilton Depression Rating Scale.Results Alpha diversity indexes were reduced in DKD patients, particularly those with ESRD. Beta diversity analysis revealed that the gut microbial compositions of DKD patients were different with healthy individuals whereas similar compositions were observed in DKD patients. Taxon differential analysis showed that when compared with the controls, DKD patients exhibit distinct microbial profiles including reduced abundances of butyrate-produced, anti-inflammatory bacteria Faecalibacterium, Lachnospira, Roseburia Lachnoclostridium, and increased abundances of pro-inflammatory bacteria Collinsella, Streptococcus etc. These distinctive genera presented consistent associations with renal dysfunction, as well as psychological distress, especially in DKD patients.Conclusions DKD patients, especially those who have progressed to ESRD, exhibit unique characteristics in their gut microbiota that are associated with both renal dysfunction and psychological distress. The gut microbiota may be a significant factor in the deterioration of DKD and its eventual progression to ESRD.
引用
收藏
页数:12
相关论文
共 45 条
  • [1] Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
  • [2] 2-S
  • [3] Diabetic Kidney Disease Back in Focus: Management Field Guide for Health Care Professionals in the 21st Century
    Alicic, Radica
    Nicholas, Susanne B.
    [J]. MAYO CLINIC PROCEEDINGS, 2022, 97 (10) : 1904 - 1919
  • [4] Integrated metagenomics identifies a crucial role for trimethylamine-producing Lachnoclostridium in promoting atherosclerosis
    Cai, Yuan-Yuan
    Huang, Feng-Qing
    Lao, Xingzhen
    Lu, Yawen
    Gao, Xuejiao
    Alolga, Raphael N.
    Yin, Kunpeng
    Zhou, Xingchen
    Wang, Yun
    Liu, Baolin
    Shang, Jing
    Qi, Lian-Wen
    Li, Jing
    [J]. NPJ BIOFILMS AND MICROBIOMES, 2022, 8 (01)
  • [5] Gut microbiota in the pathogenesis and therapeutic approaches of diabetes
    Crudele, Lucilla
    Gadaleta, Raffaella Maria
    Cariello, Marica
    Moschetta, Antonio
    [J]. EBIOMEDICINE, 2023, 97
  • [6] Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)
    de Boer, Ian H.
    Khunti, Kamlesh
    Sadusky, Tami
    Tuttle, Katherine R.
    Neumiller, Joshua J.
    Rhee, Connie M.
    Rosas, Sylvia E.
    Rossing, Peter
    Bakris, George
    [J]. KIDNEY INTERNATIONAL, 2022, 102 (05) : 974 - 989
  • [7] Alteration of gut microbial profile in patients with diabetic nephropathy
    Du, Xi
    Liu, Jia
    Xue, Yu
    Kong, Xiangyun
    Lv, Chunxiao
    Li, Ziqiang
    Huang, Yuhong
    Wang, Baohe
    [J]. ENDOCRINE, 2021, 73 (01) : 71 - 84
  • [8] 中华医学会肾脏病学分会专家组, 2021, [中华肾脏病杂志, Chinese Journal of Nephrology], V37, P255
  • [9] Lipid management in patients with chronic kidney disease
    Ferro, Charles J.
    Mark, Patrick B.
    Kanbay, Mehmet
    Sarafidis, Pantelis
    Heine, Gunnar H.
    Rossignol, Patrick
    Massy, Ziad A.
    Mallamaci, Francesca
    Valdivielso, Jose M.
    Malyszko, Jolanta
    Verhaar, Marianne C.
    Ekart, Robert
    Vanholder, Raymond
    London, Gerard
    Ortiz, Alberto
    Zoccali, Carmine
    [J]. NATURE REVIEWS NEPHROLOGY, 2018, 14 (12) : 727 - 749
  • [10] Gut-Derived Protein-Bound Uremic Toxins
    Graboski, Amanda L.
    Redinbo, Matthew R.
    [J]. TOXINS, 2020, 12 (09)